Cognitive impairment in patients with multiple sclerosis
Descripción del Articulo
Multiple sclerosis is an inflammatory, autoimmune and neurodegenerative central nervous system disease characterized by motor and sensitive function loss; it is considered to be one of the principal causes of disability in young adults. Recently, cognitive impairment has gain considerable attention...
| Autores: | , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2018 |
| Institución: | Universidad Nacional Mayor de San Marcos |
| Repositorio: | Revistas - Universidad Nacional Mayor de San Marcos |
| Lenguaje: | español |
| OAI Identifier: | oai:ojs.csi.unmsm:article/15641 |
| Enlace del recurso: | https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641 |
| Nivel de acceso: | acceso abierto |
| Materia: | Multiple Sclerosis Central Nervous System Cognitive Dysfunction Esclerosis Múltiple Sistema Nervioso Central Disfunción Cognitiva |
| id |
REVUNMSM_8ad3a4c56acfdf8b98ae67a966742610 |
|---|---|
| oai_identifier_str |
oai:ojs.csi.unmsm:article/15641 |
| network_acronym_str |
REVUNMSM |
| network_name_str |
Revistas - Universidad Nacional Mayor de San Marcos |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Cognitive impairment in patients with multiple sclerosis Deterioro cognitivo en pacientes con esclerosis múltiple |
| title |
Cognitive impairment in patients with multiple sclerosis |
| spellingShingle |
Cognitive impairment in patients with multiple sclerosis Custodio, Nilton Multiple Sclerosis Central Nervous System Cognitive Dysfunction Esclerosis Múltiple Sistema Nervioso Central Disfunción Cognitiva |
| title_short |
Cognitive impairment in patients with multiple sclerosis |
| title_full |
Cognitive impairment in patients with multiple sclerosis |
| title_fullStr |
Cognitive impairment in patients with multiple sclerosis |
| title_full_unstemmed |
Cognitive impairment in patients with multiple sclerosis |
| title_sort |
Cognitive impairment in patients with multiple sclerosis |
| dc.creator.none.fl_str_mv |
Custodio, Nilton Montesinos, Rosa López-Góngora, Mariana |
| author |
Custodio, Nilton |
| author_facet |
Custodio, Nilton Montesinos, Rosa López-Góngora, Mariana |
| author_role |
author |
| author2 |
Montesinos, Rosa López-Góngora, Mariana |
| author2_role |
author author |
| dc.subject.none.fl_str_mv |
Multiple Sclerosis Central Nervous System Cognitive Dysfunction Esclerosis Múltiple Sistema Nervioso Central Disfunción Cognitiva |
| topic |
Multiple Sclerosis Central Nervous System Cognitive Dysfunction Esclerosis Múltiple Sistema Nervioso Central Disfunción Cognitiva |
| description |
Multiple sclerosis is an inflammatory, autoimmune and neurodegenerative central nervous system disease characterized by motor and sensitive function loss; it is considered to be one of the principal causes of disability in young adults. Recently, cognitive impairment has gain considerable attention because it is a frequent symptom that causes disability. Cognitive impairment it is present in 40 to 65% of patients and affects speed of information processing, complex attention, working memory, visual and verbal memory, verbal fluency and executive functions. It may be present in radiologically isolated syndrome, clinically isolated syndrome and in the different stages of the disease; it is responsible for patient’s dependence and for the difficulties to maintain or get an employment. Cognitive impairment is associated to thalamic atrophy and a correlation with brain atrophy and cerebral lesional volume has been observed. Different evaluation tools are available, there are 5 minutes short screening tests and comprehensive 90 minutes batteries. Regarding cognitive impairment treatment, there is not a specific pharmacological treatment, nevertheless, disease modifying therapies could have a favorable influence on cognitive function because of their effects in the reduction of inflammatory activity and brain atrophy. There are no conclusive data about the efficacy of cognitive stimulation because of the diverse techniques employed and the different measures used to evaluate the results of the interventions. |
| publishDate |
2018 |
| dc.date.none.fl_str_mv |
2018-12-30 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641 10.15381/anales.v79i4.15641 |
| url |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641 |
| identifier_str_mv |
10.15381/anales.v79i4.15641 |
| dc.language.none.fl_str_mv |
spa |
| language |
spa |
| dc.relation.none.fl_str_mv |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641/13440 |
| dc.rights.none.fl_str_mv |
Derechos de autor 2018 Anales de la Facultad de Medicina https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Derechos de autor 2018 Anales de la Facultad de Medicina https://creativecommons.org/licenses/by-nc-sa/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana |
| publisher.none.fl_str_mv |
Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana |
| dc.source.none.fl_str_mv |
Anales de la Facultad de Medicina; Vol. 79 No. 4 (2018); 338-345 Anales de la Facultad de Medicina; Vol. 79 Núm. 4 (2018); 338-345 1609-9419 1025-5583 reponame:Revistas - Universidad Nacional Mayor de San Marcos instname:Universidad Nacional Mayor de San Marcos instacron:UNMSM |
| instname_str |
Universidad Nacional Mayor de San Marcos |
| instacron_str |
UNMSM |
| institution |
UNMSM |
| reponame_str |
Revistas - Universidad Nacional Mayor de San Marcos |
| collection |
Revistas - Universidad Nacional Mayor de San Marcos |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1795238257022205952 |
| spelling |
Cognitive impairment in patients with multiple sclerosisDeterioro cognitivo en pacientes con esclerosis múltipleCustodio, NiltonMontesinos, RosaLópez-Góngora, MarianaMultiple SclerosisCentral Nervous SystemCognitive DysfunctionEsclerosis MúltipleSistema Nervioso CentralDisfunción CognitivaMultiple sclerosis is an inflammatory, autoimmune and neurodegenerative central nervous system disease characterized by motor and sensitive function loss; it is considered to be one of the principal causes of disability in young adults. Recently, cognitive impairment has gain considerable attention because it is a frequent symptom that causes disability. Cognitive impairment it is present in 40 to 65% of patients and affects speed of information processing, complex attention, working memory, visual and verbal memory, verbal fluency and executive functions. It may be present in radiologically isolated syndrome, clinically isolated syndrome and in the different stages of the disease; it is responsible for patient’s dependence and for the difficulties to maintain or get an employment. Cognitive impairment is associated to thalamic atrophy and a correlation with brain atrophy and cerebral lesional volume has been observed. Different evaluation tools are available, there are 5 minutes short screening tests and comprehensive 90 minutes batteries. Regarding cognitive impairment treatment, there is not a specific pharmacological treatment, nevertheless, disease modifying therapies could have a favorable influence on cognitive function because of their effects in the reduction of inflammatory activity and brain atrophy. There are no conclusive data about the efficacy of cognitive stimulation because of the diverse techniques employed and the different measures used to evaluate the results of the interventions.La esclerosis múltiple es una enfermedad inflamatoria, autoinmune y neurodegenerativa del sistema nervioso central caracterizada por pérdida de la función motora y sensitiva; es considerada una de las principales causas de discapacidad en el adulto joven. Recientemente, se le ha dado gran importancia al deterioro cognitivo, por ser un síntoma frecuente y discapacitante. Este deterioro está presente en un 40 a 65% de los pacientes y afecta la velocidad de procesamiento de información, atención compleja, memoria de trabajo, memoria visual y verbal, fluencia verbal y funciones ejecutivas. Se puede presentar en el síndrome radiológico aislado, en el síndrome clínico aislado y en las diferentes fases de la enfermedad; además, es el responsable de la dependencia de algunos pacientes y de las dificultades para mantener o conseguir empleo. Este déficit cognitivo se asocia a atrofia del tálamo y se ha observado una correlación con las medidas de atrofia y con el volumen lesional cerebral. Existen diferentes herramientas para su evaluación; hay pruebas de cribado breves de 5 minutos de duración, hasta baterías extensas de 90 minutos. Respecto al tratamiento de las alteraciones cognitivas, no existe un tratamiento farmacológico específico; sin embargo, se considera que los fármacos modificadores de la enfermedad podrían tener una influencia favorable en la función cognitiva por sus efectos en la reducción de la actividad inflamatoria y la atrofia cerebral. En cuanto a la estimulación cognitiva, no existen datos concluyentes por las diferentes técnicas empleadas y las distintas medidas utilizadas para evaluar los resultados de las intervenciones.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2018-12-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1564110.15381/anales.v79i4.15641Anales de la Facultad de Medicina; Vol. 79 No. 4 (2018); 338-345Anales de la Facultad de Medicina; Vol. 79 Núm. 4 (2018); 338-3451609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641/13440Derechos de autor 2018 Anales de la Facultad de Medicinahttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/156412019-01-18T09:35:14Z |
| score |
13.932913 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).